|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
1 event,
-
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national |
2 events,
Featured
The leading annual conference on biodefense, biosecurity and biological threats, ASM Biothreats, will be held January 28–30, 2020 in Arlington, Virginia. Hosted by the American Society for Microbiology, this one-of-a-kind meeting draws stakeholders from government, academia and industry for an important exchange of knowledge and ideas that will shape the future of high consequence pathogen 
Featured
The 11th meeting of the Tick-borne Disease Working Group (TBDWG) will be held on January 28 and 29, 2020, from 9:00 a.m. to 4:30 p.m. ET on both days (times subject to change). The meeting will be held at the in Washington D.C. and by webcast. Preregistration for public members is advisable and can be |
1 event,
|
2 events,
Meeting registration will close on January 31, 2020 for the U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity. The meeting will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. The meeting is sponsored by the Chemical Countermeasures Research Program (CCRP),
-
The CDC will hold a COCA (Clinicians Outreach and Communication Activity) call this afternoon with their latest recommendations. Due to the high demand we anticipate for this COCA Call, we kindly ask participants to access it in a group format, if at all possible, to allow for the maximum number of participants to attend. Target audience: Physicians |
0 events,
|
0 events,
|
|
|
2 events,
-
The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under FDA’s emergency use authorization (EUA) to advance to full marketing status. A roadmap for diagnostic evaluations during emergencies would help enable stakeholders
-
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national |
0 events,
|
0 events,
|
1 event,
-
In response to news and concerns about the respiratory illness outbreak caused by a novel coronavirus initially identified in China, the Yale Institute for Global Health, Yale School of Public Health and the Global Health Justice Partnership will hold a discussion and question and answer session on Thursday, February 6, 2020. Panelists will address the |
0 events,
|
0 events,
|
0 events,
|
|
3 events,
-
Hudson Institute and the Bipartisan Commission on Biodefense will host a panel discussion on the ongoing coronavirus outbreak and how the United States can respond to the growing outbreak effectively. Confirmed infections of the coronavirus in China have exceeded that of the 2002-2003 SARS epidemic, with thousands more suspected cases. As the number of cases
-
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national
-
The UCLA Fielding School of Public Health and the UCLA Center for Chinese Studies present The Novel Coronavirus: What Do We Know and What's Next?, a symposium and reception. The novel coronavirus (2019-nCoV) was first reported in Wuhan, China in December 2019. On January 30, 2020, the WHO declared the outbreak a public health emergency of |
1 event,
The World Health Organization will host a Global research and innovation forum 11-12 February in Geneva to mobilize international action in response to the novel coronavirus (2019-nCoV) emergency. The event is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R), and brings together key players including leading scientists as well as |
2 events,
-
The U.S. Senate Committee on Homeland Security & Governemental Affairs will convene a Full Committee hearing on Feb.12 to examine protecting the United States from global pandemics. ROUNDTABLE: Are We Prepared? Protecting the U.S. from Global Pandemics will February 12, 2020 09:30 AM Location: SD-G50, Dirksen Senate Office Building The meeting will air on CSPAN. See |
0 events,
|
1 event,
CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and |
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
2 events,
-
PHEP Recipient Monthly Conference Call Scheduled for February 19 CDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday, February 19. Participant information is provided below. Conference Call Information Bridge Line: (888) 566-1873 Participant Code: 3358383 The Public Health Emergency Preparedness (PHEP) cooperative
-
Target Audience: Health care providers (including primary care physicians & nursing professionals) Key Note Speakers: Dr. Gerald Evans Chair of the Division of Infectious Diseases, Professor of Medicine, Queens University; Attending Staff, Kingston Health Sciences Centre Dr. Piotr Oglaza Medical Officer of Health & CEO, Hastings Prince Edward Public Health Yvonne DeWit, Epidemiologist, Hastings Prince |
1 event,
The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing |
0 events,
|
0 events,
|
0 events,
|
|
1 event,
-
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national |
1 event,
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and |
2 events,
A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a one day workshop on Feb 26, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. The workshop will identify a range |
1 event,
-
The House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. Witnesses will include U.S. government officials who have led the response to the virus. Date: Thursday, February 27, 2020 Time: 2:00 p.m. EST Subject: Coronavirus Disease 2019: The U.S. and |
2 events,
HHS-NIH-NIAID-BAA2020-1 Research Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68 Supports the development of inactivated Enterovirus D68 vaccines, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial. Due Date: February 28, 2020, by 3 p.m. Eastern Time Learn more
-
Join the next FoNS Research Seminar and learn the cutting-edge research on infectious diseases taking place across the Faculty The Faculty regularly organises events that showcase its strong research areas in order to stimulate new collaborations and discussions around a topic. The next one will be on the topic of “Infectious Diseases”. Our highlighted speakers |
1 event,
The 16th CDC International Symposium on Biosafety – Laboratory Safety and Security for Clinical, Public Health, Research and Animal Care will be held 29 February – 4 March, 2020 in Atlanta, Georgia. Stakeholders will learn about the soon-to-be-released 6th edition of the BMBL, gaps in clinical and research biosafety, risk management tools for animal facilities, |
